Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Healing Bottoms Champion Malt & Molasses Breakfast is a Gut Changer


“Healing Bottoms Malt & Molasses Serum is Delicious & Life Changing”

“The affects have been outstanding so far. After 2 months I’ve gained 7 lbs and my stool has gone from watery clumps to a consistent form. The taste is also A+!”

Consumers are enjoying the flavor of a hot breakfast cereal and molasses serum specifically designed to Maintain/Gain Weight, or Soothe Digestive ailments like Inflammation conditions along with the following:

  • Enhances Good Bacteria in the Stomach & Colon
  • Maintain Weight (1 Serv) or Gain Weight (2 Serv)
  • Stifles Gut, Intestinal & Bowel Inflammation
  • Stifles Frequent Bathroom Runs
  • Healthier Thicker Stool Without Constipation
  • Omega-3 Fatty Acids, Vitamin A & D
  • Bowel Regulator (2 servings A Day Control Diarrhea)
  • Reduces Damage from Toxins & Free Radicals
  • Modulate Immune Response to Ongoing Damage in Gastrointestinal Tract
  • Added Dietary Nutrients, Vitamins and Minerals “

How does this Breakfast taste and does it work?

Consumers reported the Breakfast duo to be tasty, hot, filling, and truly addictive. Others say it’s a yummy dessert or midnight munchie that hits the spot. It has rich molasses flavors and light lemon notes throughout, that make customers tongue beg for more. The benefits are just the icing on the cake. While this Breakfast is yummy it also delivers.

Who is Healing Bottoms?

Healing Bottoms is a holistic Pharmacy made up of a small Team of Professional Homeopath Researchers. HB is a Doctor recommended, Household Brand, Family Practice since 2009, Based in the US. HB offers upper and lower Digestive Anti-Inflammatory and Restorative Treatment and Vaginal Cyst. HB Product line consist of Max Turmeric Supplements, Turmeric Suppositories, Thrombosed Hemorrhoid Removal, Wound Healing Wipes, Detox Tea, Malt Breakfast / Serum, and Bartholin Gland Cyst Drainage. To Purchase their Amazing Products, go on Amazon or Order Direct for %10 Discount & Lower Shipping Cost. http://www.healingbottoms.com

What are Consumers saying?

Stan T. VERIFIED PURCHASE 2020

“I look forward to eating 2 servings of HB Breakfast a day. The affects have been outstanding so far. After 2months I’ve gained 12lbs and my stool has gone from watery clumps to a consistent form.”

Is it worth the price?

YES. Colitis is no fun and neither is diarrhea, having a product that omits both is major. The icing on the cake is the fact that it lowers inflammation as well as the other added benefits. The imported Grade A ingredients alone are more than worth the price. When you add in the tedious heat/cool process of homeopathic preparation and hand measurements, production of each product to guarantee results each time also points to yes. HB is committed spending time and labor to create quality and exemplify the spirit of excellence. Needless to say, I’m giving it 5 stars. Not only has HB treatment been a life saver online their Foundation works hard to treat the financially disadvantaged. They have saved hundreds of lives from going under the knife. For more information visit https://www.healingbottoms.com/#/

Share article on social media or email:

Catalent to Discuss Data-Driven Development and Patient-Focused Dose Design Strategies at AAPS PharmSci 360


Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that its experts will present at the upcoming American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 event, which takes place virtually from Oct. 26 – Nov. 5, 2020.

On Oct. 26, at 2 p.m. ET, Lisa Caralli, Director of Science and Technology, will present “Data-Driven Strategies to Accelerate Your Molecule’s Development Path”. Ms. Caralli will discuss evidence-based approaches that help avoid development pitfalls and de-risk the path to clinic, including physiologically-based pharmacokinetic (PBPK) modeling, parallel formulation screening, API sparing techniques and optimal early dosing strategies.

Traditional drug development is largely driven by API pharmaceutics, cost and timelines, and can overlook patients’ needs, which may result in a lack of compliance. On Nov. 4, at 9 a.m. ET, Cornell Stamoran, Ph.D., Vice President of Corporate Strategy and founder of the Catalent Applied Drug Delivery Institute (“Catalent Institute” – http://www.drugdeliveryinstitute.com), and William Chin, Ph.D., Manager, Global Scientific Affairs, will discuss dose design strategies that can be employed to better serve patients in their presentation, “Patient-Focused Drug Design: A Structured Approach to Dose Form Design to Develop Better Treatments that Address Patient Needs”.

Ms. Caralli has over 27 years of industry experience, and in her role at Catalent works with pharmaceutical companies to identify appropriate development pathways for early development drug candidates. She has previously held roles at Ionis Pharmaceuticals and Amylin Pharmaceuticals, having begun her career at the Immune Response Corporation. Ms. Caralli holds a bachelor’s degree in biochemistry from the University of California, Davis, California.

Dr. Stamoran leads Catalent’s strategic planning, market intelligence and government affairs efforts. He also founded and serves as Co-Chair of the Catalent Institute. He has spent more than 30 years engaged in the healthcare industry, including over 25 years in advanced drug and biologic delivery and outsourcing.

Dr. Chin has experience in in vitro and in vivo evaluation of pharmaceutical formulations and drug delivery systems, specializing in oral solid dosage formulation, Phase 1 and 2 process development for pediatrics, and first-in-human trials. Dr. Chin received his doctoral degree from the Department of Pharmacy at the National University of Singapore.

For more information, please visit https://www.catalent.com/events/aaps-2020/.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Greenway Health Recognizes Customers Health Choice Network and HealthLinc at MGMA 2020


News Image

“Thanks to partners like Greenway Health which provided critical services, technology and support during these times, we were able to truly focus on fulfilling our mission while also protecting the center’s quality care awards and overall bottom line.”

Greenway Health, a leading health information technology services provider, is pleased to recognize its long-time customers Health Choice Network (HCN) and HealthLinc for their receipt of the Medical Group Management Association’s (MGMA) ‘Rise Above’ Recognition, highlighting the work of healthcare leaders and organizations as they overcame daily challenges as a result of the COVID-19 pandemic. The centers will be acknowledged during MGMA’s virtual Medical Practice Excellence Conference (MPEC) from Oct. 19-21. Both organizations leverage Greenway to power their health tech stack, leading with Intergy EHR and Greenway Revenue Services.

HCN is a successful nation-wide collaboration of health centers, health center-controlled networks and partners. With 52 safety-net organizations in 19 states serving approximately 2.2 million patients, HCN led several frontline initiatives throughout the pandemic, such as drive through and walk-up testing sites, to delivering critically-needed personal protective equipment throughout the city, all while continuing to provide quality patient care to the community at large.

“Throughout the COVID-19 pandemic we have increased our efforts and resources in order to enhance our commitment to serving our community and ensuring the provision of high-quality, affordable, community-based health care to the underserved and families,” said Alex Romillo, president/CEO of HCN. “Thanks to partners like Greenway Health which provided critical services, technology and support during these times, we were able to truly focus on fulfilling our mission while also protecting the center’s quality care awards and overall bottom line.”

In addition, HealthLinc, a not-for-profit Federally Qualified Health Center (FQHC) that provides health services to people of all ages regardless of a patient’s ability to pay, quickly expanded telehealth and established drive through facilities at the height of the pandemic in order to increase access to quality patient care in its communities. Providing a variety of patient services, including primary medical, dental, optometry, behavioral health and more, the center was a lifeline for hundreds of patients throughout the pandemic.

“Patient care and safety have always been our top priority, and the pandemic only served to strengthen our commitment to ensuring access to quality care to those we serve,” said Beth Wrobel CEO of HealthLinc. “Leveraging innovative health technologies was key to making this happen. Telehealth solutions that integrate with our EHR platform and RCM services that streamline and give us better insight into our financial practices have been critical to enabling us to continue delivering health services to our community throughout COVID-19.”

In addition to recognizing the success of these customers during the 2020 virtual MPEC event, Greenway will also be a hosting several informational sessions. The first, “Leadership Roundtable: Virtual care and cybersecurity,” hosted by Greenway’s Chief Product and Technology Officer David Cohen and other executives will take place on Wednesday, Oct. 21 at 1:15 p.m. EST. Interested attendees can register here. The second, “Leadership Roundtable: Leading a successful workplace in uncertain times,” hosted by Greenway’s Chief Transformation Officer Michele Streitmatter will take place Wednesday, Oct. 21 at 2:45 p.m. EST.

“As a company dedicated to the advancement of health, we understand the challenges facing our customers and communities during such unprecedented times, and we commend these practices and providers for their commitment to patient care,” said Pratap Sarker, president of Greenway Health. “We are committed to providing our customers with the innovative tools and technologies they need to continue improving outcomes, streamlining workflows and maintaining business continuity as we monitor the status of COVID-19 here in the U.S. and around the world.”

To learn more or speak with a member of the team, visit Greenway’s virtual MPEC booth. For more information on Greenway’s solutions and commitment to its ambulatory care customers, visit http://www.greenwayhealth.com.

About Greenway Health

Improving healthcare through innovation is at the heart of Greenway Health’s work. We provide electronic health record (EHR), practice management and revenue cycle management solutions that help practices in multiple specialties grow profitably, remain compliant, work more efficiently and improve patient outcomes. Our team of clinical, financial and technology experts serve as trusted advisers, committed to our customers’ success. Greenway works with over 55,000 providers across multiple specialties, which translates into millions of lives touched daily by our solutions. For details on how we can work together to build a more efficient healthcare system, visit http://www.greenwayhealth.com, call 877-537-0063, or follow Greenway on Facebook, Twitter, and LinkedIn.

Share article on social media or email:



Dr. Joseph Singerman and Toni Fimowicz


News Image

Michelle Scherwinski, CNO at Villa Healthcare says, “When we are able to share expertise with others in the skilled nursing industry, it makes each of us better, and most importantly, it makes care for nursing home residents better.”

Villa Healthcare applauds Dr. Joseph Singerman and Toni Fimowicz who are invited speakers at the National Association of Directors of Nursing Administration in Long Term Care (NADONA) National Conference. The NADONA National Conference is the largest annual meeting of nurse executives working in long-term and post-acute care. With over 35 state chapters, NADONA continues to be the largest organization representing nurses working in long-term care settings such as assisted living, skilled nursing, mentally challenged/developmentally disabled, and rehabilitation facilities.

Dr. Singerman, Chief Medical Officer at Villa, is instrumental in Villa’s efforts to grow and develop clinical programs and capabilities at each center. He provides leadership and guidance to Villa’s medical directors and responds to emerging clinical trends to help position each center to be a clinical leader. Earning his Bachelor’s degree in Talmudic Law from Ner Israel Rabbinical College, Dr. Singerman went on to complete medical school at Michigan State University. He completed his residency at Botsford Hospital, and is board-certified in Internal Medicine. Currently on staff at William Beaumont hospital in Michigan and affiliated with the Detroit Medical Center (DMC), Dr. Singerman was voted one of the top doctors in the state of Michigan by his peers, leading to a spot on Hour Detroit’s Top Docs List for the last six years. When not pursuing his passions in the medical arena, Dr. Singerman enjoys spending time with his wife and their seven children.

Dr. Singerman’s presentation will help attendees understand both skills and strategies that can easily reduce unplanned discharges from SNFs. He will walk the group through concepts such as Early intervention and management of acute situation skills, Medical reduction and palliative care, and Chart review.

Toni Fimowicz began her career in hospitality and transitioned to skilled nursing in 2016. Guest experience is her forte – a skill she brought from the hotel world into skilled nursing. She is the National Director of Organizational Development where she leverages patient and employee feedback to provide support for training, succession planning, and program development with the goal of improving clinical outcomes in an employee-centered care environment. Toni lives in northern Chicago and is pursuing her Master’s degree in Organizational Leadership and Learning.

Toni’s session presents new employee training as one component that can improve turnover statistics for long-term care settings. She will enable the audience members to assess their employee training processes, understand how to create a plan to get from their current training to desired state, and learn how to regularly refine new employee training to ensure continuous improvement. While employee training is not the sole driver of turnover, the impact it has should not be ignored.    

Michelle Scherwinski, Chief Nursing Officer at Villa Healthcare says, “We could not be more proud of and excited for our colleagues to share their knowledge and experience with the NADONA audience. When we are able to share expertise with others in the skilled nursing industry, it makes each of us better, and most importantly, it makes care for nursing home residents better.”

We’re Villa, and we make people better. Of course, we’re focused on quality care and good outcomes. But we’re here to do so much more. Villa’s leadership has a vision of rising above the status quo—of never settling, and of shattering the old image of this industry. We’ve always wanted to be a part of something greater, and we’re making that a reality. Our commitment to our people, our environment and clinical programs will allow us to fulfill our mission of making people better. For more information, please visit http://www.VillaHC.com.

####

Share article on social media or email:

Implementation in Clinical Trials Through The Development of Clinical Utility, Upcoming Webinar Hosted by Xtalks


Noninvasive approaches, commonly termed liquid biopsies, for obtaining genomic biomarker data have rapidly advanced to provide a less-invasive potential alternative for determining the right therapy for each patient based on their tumor, and identifying and monitoring patients in clinical trials.

The oncology therapeutic pipeline has grown substantially over the last decade, with thousands of drug candidates currently in development. A majority of these drug candidates specifically target driver alterations associated with solid tumors. Therefore, accurate biomarker testing is a key component of elucidating the genetic signature of the disease, potential resistance mechanisms, and for identifying the patient population with the greatest potential to elicit more efficacious responses. The conventional approach to obtaining patient samples to study these biomarkers is an invasive tissue biopsy. Recently, noninvasive approaches, commonly termed liquid biopsies, for obtaining genomic biomarker data have rapidly advanced to provide a less-invasive potential alternative for determining the right therapy for each patient based on their tumor, and identifying and monitoring patients in clinical trials.

In this webinar, featured speakers will highlight the role of biomarker identification and testing, the history and advancements in the field of liquid biopsies, and discuss how liquid biopsy testing is currently being applied in a diagnostic setting for patients with tumor types such as non-small cell lung cancer.

Join Steven Anderson, PhD, Chief Scientific Officer, Covance Drug Development and Taylor Jensen, PhD, Director, Research and Development LabCorp in a live webinar on Monday, November 2, 2020 at 10am EST (3pm GMT/UK).

For more information or to register for this event, visit Liquid Biopsies: Implementation in Clinical Trials Through The Development of Clinical Utility.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

A Review of Recent Case Studies, Upcoming Webinar Hosted by Xtalks


From changing inflight studies to creating entirely new studies, several thought leaders will share their experiences with DCT approaches and how they contributed to trial continuity and increased the resilience of trials.

When the global clinical trial industry was suddenly forced to adapt to unprecedented challenges, traditional trial conduct models were upended. Some trials were delayed or even cancelled. Yet other trials thrived and still more were able to restart after adopting decentralized clinical trial (DCT) methodologies.

In this educational webinar, speakers will review recent case studies and walk through several unique situations from the last seven months. From changing inflight studies to creating entirely new studies, several thought leaders will share their experiences with DCT approaches and how they contributed to trial continuity and increased the resilience of trials.

From technology platforms to home health care services and mobile devices, attendees will learn how several new DCT solutions are being applied to sponsor’s trial needs, and how sponsor needs are directing the evolution of these flexible services in real time. Join our featured speakers to understand the ongoing evolution of trial models to become more efficient, more convenient and better able to adapt to the changing world.

Join Bola Oyegunwa, Vice President & Head of Decentralized Clinical Trials, Covance; Gail Adinamis, Chief Executive Officer, GlobalCare Clinical Trials, LLC; Joan Meyer, PhD, Executive Director, Inflammation, Infectious Disease & General Medicine, Covance; and Christian Knaus, Senior Director, Client Development, SnapIoT, Inc. in a live webinar on Thursday, October 29, 2020 at 10am EDT (2pm GMT/UK).

For more information or to register for this event, visit Why Every Trial Should be a Decentralized Clinical Trial: A Review of Recent Case Studies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Global Wellness Summit Announces Agenda for Historic 2020 Conference


The GWS announced an impressive roster of keynotes, presenters and panels for the 14th annual GWS taking place both in-person and worldwide via the recently announced Virtual Access Package.

2020 may be shorthand for perfect vision, but few could have imagined what we have seen this year. The challenges are immense, but so are the opportunities, especially for wellness.

The Global Wellness Summit (GWS), the foremost gathering of international leaders in the multitrillion-dollar global wellness economy, today announced an impressive roster of keynotes, presenters and panels for the 14th annual GWS taking place both in-person at The Breakers Palm Beach and worldwide via the recently announced Virtual Access Package.

Below is a snapshot of the presenters and their topics; the full list can be found at this link and is updated frequently:

-Ophelia Yeung, Katherine Johnston, Tonia Callender, research team from The Global Wellness Institute, will present a groundbreaking report: “Defining the Mental Wellness Economy”

-James Nestor, will present on his New York Times best-selling book: “Breath: The New Science of a Lost Art”

-Amanda Ho, co-founder, Regenerative Travel, in conversation with Catherine Feliciano-Chon, founder & managing director, CatchOn: “Regenerative Travel, Eco-Luxury and Social Impact—Strange and Powerful Bedfellows”

-Raphael Rakowski, co-founder of Medically Home, and Adventist Health President, Bill Wing will present: “Taking Matters into Your Own Home—Traditional Healthcare Disrupted”

-Marisa Peer, best-selling author, sought-after therapist to celebrities and royalty, will present: “Reset Yourself—the Next Level of Empowerment”

-Rick Stollmeyer, founder of the multibillion-dollar wellness technology platform, Mindbody, on his recently released book: “Building a Wellness Business that Lasts: How to Make a Great Living Doing What You Love”

-Paul Leone, CEO, The Breakers Palm Beach, in conversation with Susie Ellis (GWS chair & CEO): “Navigating Hospitality in the Time of a Pandemic”

-Amir Alroy, co-founder, Welltech1, on the robust wellness technology sector: “Innovations from the Start-Up Nation”

-Shoshana Ungerleider, MD, founder, End Well Project, in conversation with B.J. Miller, MD, founder of Mettle Health: “Resetting Society’s Discourse on Death and Dying”

-Michael Breus, MD, sleep expert and author: “How to be Better in Bed—Sleeping Through the Pandemic”

-Michael C. Bush, founder of Great Place to Work, will present never-before shared research on the impact of the pandemic on the workplace and workforce, and the ROI of wellness and inclusivity in business

-Chris Rondeau, CEO, Planet Fitness, in conversation with C. Victor Brick, CEO, P.F. Growth Partners, LLC, on fitness as a predictor of health and immunity, and the challenges and opportunities of this moment in time

-Nicola Finley, MD, Health & Healing, Canyon Ranch: “Dancing into Wellness—The Medical Benefits of Unbridled Joy”

-Dr. Bhupendra Kumar Modi, chairman of Smart Group, will present on the Wellness Economy in India

-Ray Lewis, Baltimore Ravens football legend, entrepreneur: “8 Pillars of a Full Life”

-Zev Suissa, chief innovation officer, eMindful, Inc., will present on mindfulness technologies impacting the new work paradigm

-Richard Carmona, MD, 17th Surgeon General of the US: “Life Must Go On—Living with a New Reality”

-Anna Bjurstam, wellness pioneer, Six Senses, strategic advisor, Pegasus Capital Advisors: “Dreaming the World We Want”

-John Kao, renowned innovator, strategic advisor, author, will present a keyboard keynote while playing Jazz piano: “Wellness is Ripe for Disruption”

Panels will focus on topics as wide-ranging as Wellness Real Estate and Communities; Mental Wellness; Wellness Technologies; Investing in Wellness; Science of Sleep; Hospitality; Travel & Tourism; Sustainability and Regeneration; Wellness Media and Trends; Achieving Health Equity in Minority Communities; and more. Critical to the conversation will be “Resetting Sessions,” where moderators will lead the delegates—in-person and virtually—through a series of brainstorming discussions with the purpose of charting a course for the future of the industry.

The Summit also features its legendary Shark Tank of Wellness student competition; the presentation of Global Wellness Awards including the inaugural Global Wellness Summit Prize, given to the winner of the “Call for Wellness Innovations” competition; an update on “The Wellness Moonshot: A World Free of Preventable Disease”; and the Tech Innovation Pavilion, featuring global companies involved in cutting-edge wellness technologies.

“2020 may be shorthand for perfect vision, but few could have imagined what we have seen this year. The challenges are immense, but so are the opportunities, especially for wellness. We are taking this moment to gather industry leadership to forge a plan for the future. The theme of “Resetting the World with Wellness” was chosen with intent and a clear mission, and we have invited some of the best minds in the world to share their strategies for a strong, healthy and conscious future,” said Nancy Davis, chief creative officer and executive director of the GWS and curator of the agenda.

Capacity at the 2020 Summit at The Breakers is very limited. Register here for either the in-person Summit or the Virtual Access Package.

Images can be found here.

About the Global Wellness Summit: The Global Wellness Summit is an invitation-only international gathering that brings together leaders and visionaries to positively shape the future of the $4.5 trillion global wellness economy. Held in a different location each year, Summits have taken place in the US, Switzerland, Turkey, Bali, India, Morocco, Mexico, Austria, Italy and Singapore. The 14th annual Summit will take place at The Breakers Palm Beach, FL, from November 8–11, 2020. The 2021 GWS will be held in Tel Aviv, Israel, November 15–18.

Alfredo Arrojas, M.D. Joins Rothman Orthopaedics – Florida


News Image

His strong passion for providing high level care for his patients in the Orlando market plus his commitment to evidence-based medicine makes him a natural fit for the model we are building in Central Florida.

Rothman Orthopaedic Institute, shortly after the announcement of a long-term partnership with AdventHealth—is pleased to announce Dr. Alfredo Arrojas, total joint reconstruction surgeon, has joined its team. Dr. Arrojas’ signing is a part of a growing list of subspecialized, fellowship trained physicians that will help lead the expansion into this market for the internationally-recognized orthopaedic practice.

“We are very excited to welcome Dr. Arrojas to the Rothman Orthopaedics family,” said Dr. Alexander R. Vaccaro, M.D., Ph.D., MBA, President of Rothman Orthopaedic Institute, Richard H. Rothman Professor and Chairman of the Department of Orthopaedics, and Professor of Neurosurgery at Thomas Jefferson University and Hospitals. “His strong passion for providing high level care for his patients in the Orlando market plus his commitment to evidence-based medicine makes him a natural fit for the model we are building in Central Florida.”

“I am a firm believer in Rothman’s core values of quality driven care,” says Dr. Arrojas. “Rothman Orthopaedics will bring a paradigm shift to Central Florida changing the primary focus to quality instead of volume. I truly believe that patients treated within a subspecialized practice, should be treated by those individuals best skilled to take care of each patients individual issues. If our top priority is providing top-notch orthopaedic care to patients, all other aspects of treatment and service will fall in line.”

Dr. Arrojas joins Rothman Orthopaedics after previously serving as an associate for a successful practice in the Kissimmee and St. Cloud, FL markets. He attended medical school at Drexel College of Medicine in Philadelphia; completed his residency at Palmetto Health/University of South Carolina-Orthopedic surgery, where he was awarded “Senior Resident of the Year” and “Resident Research of the Year;” and his fellowship at The CORE Institute Phoenix, AZ – Joint Reconstruction.

Within his specialty, Dr. Arrojas, a bilingual speaking surgeon, performs various procedures of the total joint including direct anterior total hip arthroplasty and robotic assisted total hip & knee arthroplasty. He is passionate about providing quality, compassionate care and treating every one of his patients as if they were a part of his family.

Until Rothman Orthopaedic practice sites open in early 2021, Dr. Arrojas through Rothman’s partnership with AdventHealth, will treat patients beginning in November 2020 in an AHMG office in Oviedo, FL and operate in AdventHealth Winter Park.

Multiple physician agreements are being scheduled for release. These announcements will be a testament to the local and national interest from fellowship trained, subspecialized physicians who are committed to exceeding clinical quality and share the importance of academics and research interested in joining Rothman Orthopedics – Florida. For more information, please visit RothmanFL.com.

About Rothman Orthopaedic Institute:

Rothman Orthopaedic Institute is a world-leader in the field of orthopaedics providing communities in Pennsylvania, New Jersey, New York and most recently in Florida through its new partnership with AdventHealth. Rothman Orthopaedics provides high-quality, compassionate and affordable musculoskeletal care that is grounded in evidence-based medicine—the results of which will exceed expectations.

Rothman Orthopaedic Institute orthopaedists treat patients at 38 office locations, three of which include orthopaedic urgent care clinics. Rothman also has surgical privileges at 58 facilities across the tristate region. With experts in nine orthopaedic sub-specialties including spine, hip and knee, foot and ankle, shoulder and elbow, hand and wrist, sports medicine, physical medicine and rehabilitation, orthopaedic oncology and trauma, Rothman Orthopaedic Institute is recognized for excellence in clinical treatment methods, research, education and technology.

Consistently recognized as national and regional “Top Docs,” Rothman Orthopaedic Institute is proud to be the official team physicians for the Philadelphia Eagles, Phillies, 76ers, the iconic Radio City Rockettes, The Big East Conference, as well as over 40 college and high school teams.

For more information about Rothman Orthopaedic Institute please call 1-800-321-9999 or visit http://www.RothmanOrtho.com.

Share article on social media or email:

Zesty Paws Names Tad Godsil as New CFO


I am thrilled to be a part of the incredible Zesty Paw’s team that has not only been tremendously successful, but also has the potential for significant growth for many years to come.

Zesty Paws, a leading functional supplement brand for pets, has announced the recent appointment of Tad Godsil to Chief Financial Officer (CFO). In this role, Godsil will be responsible for strategically overseeing the finances and supporting the growth and innovation of the company and its functional pet supplement products.

“I am thrilled to be a part of the incredible Zesty Paw’s team that has not only been tremendously successful, but also has the potential for significant growth for many years to come,” said Tad Gadsil, CFO of Zesty Paws and proud owner of a Mini Goldendoodle. “Since starting, I’ve been working with the team to identify key growth drivers and optimize the investments that drive that growth. Zesty Paws has had a strong year-to-date, and we will continue the momentum into a Q4 and through the new year.”

With more than 10 years of experience as a CFO, Gadsil has a proven history of performance in the CPG space as well as in the health wellness and fitness industry with professional skills in cross-functional team leadership and in mergers and acquisitions. Prior to joining Zesty Paws, Gadsil held the position of CFO for Ancient Nutrition where he provided strategic planning and financial management to the organization. Gadsil also served as CFO for other health and wellness brands including Kellogg, Swanson Health Products and Performance Health.

“Zesty Paws is a growth-focused company with a dynamic leadership team and we are very excited to have Tad Gadsil join our family and help drive the business to meet our aggressive innovation and expansion goals,” said Steve Ball, CEO of Zesty Paws. “Tad’s success in the health industry, his experience working with a public company, his financial expertise and outstanding leadership traits make him the perfect addition to the team.”

Zesty Paws is the go-to brand for top rated pet nutrition supplements for dogs and cats that offers functional benefits with premium branded ingredients. Delivered in a treat-like format, Zesty Paws’ supplements are a health solution for addressing certain needs of cats and dogs including, Digestion, Immunity, Grooming and Behavior, among others. All Zesty Paws pet supplements are made in the United States with the best available globally sourced proven branded ingredients.

For more information about Zesty Paws, please visit ZestyPaws.com or follow them on Instagram.

ABOUT ZESTY PAWS

At Zesty Paws our passion is simple: to enable and inspire a ZEST FORT LIFE in pets and parents. We strive to be the most innovative and trusted brand in functional solutions to guide and empower pets on their journey through wellness.

We use unique formulas based on active ingredients you know and trust, and that are proven to provide tangible benefits to your pet. We have received thousands of 5-star reviews on top channels such as Amazon, Chewy and our own site. Pet parents are delighted by our commitment to innovative, high quality products that work, as well as by our unparalleled customer service. As the most trusted brand for pet’s health and wellness, the United States-based brand has been regularly recognized as a best seller on Amazon, alongside other top pet retailers. For information about Zesty Paws, please visit ZestyPaws.com or catch up with them on Instagram (@zestypaws), Facebook or Twitter (@zestypaws).

Share article on social media or email:

UT Health San Antonio physician develops device to relieve hiccups


HiccAway, the device based on science and invented to relieve hiccups. Credit UT Health San Antonio

“I was thinking, how can I improve this?” — Dr. Ali Seifi of the Long School of Medicine at UT Health San Antonio, referring to hiccups in his patients.

A neuro-intensive care physician at UT Health San Antonio has invented a science-based way to stop hiccups.

While he was working as an anesthesiologist 20 years ago, Ali Seifi, MD, FACP, FNCS, saw many surgery patients in the recovery room who developed hiccups. The annoying spasming of the diaphragm is even more of a nuisance when one has had surgery.

“I was thinking, how can I improve this?” Dr. Seifi said.

A hiccup is an involuntary contraction of the diaphragm, a thin sheet of muscle that separates the lungs from the abdomen and regulates breathing. The diaphragm contracts out of rhythm. This causes the vocal cords and larynx to swiftly close and the lungs to take in oxygen quickly. The body reacts with the classic hiccup sound.

Although hiccups usually are temporary, some cases may last for hours or days and could signal a medical problem. The longest case of hiccups reportedly lasted more than 60 years.

“There have been no clear medications for hiccups,” Dr. Seifi said. “The only drugs prescribed are psychiatry medications that do stop the spasms but make the patients sleepy. There also is no device to treat hiccups. A few devices were patented or proposed for provisional patents, but they never made it to the stage of being available to people.”

Dr. Seifi set out to invent a treatment.

His brainchild is shaped like a smoker’s pipe. On one end, the tube has two pinholes on opposite sides. These are covered by a valve or cap that can be adjusted for adult or child settings. This end is to be submerged into a cup of water.

The other end is a mouthpiece from which the user draws water through the pipe. The device is called HiccAway, a name conceived by medical students and residents attending rounds with Dr. Seifi.

“This is not a regular straw,” Dr. Seifi said. “To drink water through it, you need lots of effort and lots of negative pressure inside your chest. The valve causes you to forcefully suction the water from the cup, and when you do, after a few seconds the first sip of water enters the pipe and goes into your mouth.”

This does two things, Dr. Seifi said. Because of the severe negative suction, it pulls down the diaphragm, which triggers the phrenic nerve that regulates the diaphragm.

When the water enters the mouth, the brain wants to swallow it, so it closes the epiglottis, the flap in the throat that prevents food or water from entering the windpipe and lungs. “This is the time when the vagus nerve also gets activated,” Dr. Seifi said.

Stimulating the vagus nerve blocks signals to the vocal cords and eases hiccups.

“That was the idea that came to my mind,” Dr. Seifi said. “What if we, for a few seconds, forcefully triggered both nerves together?”

HiccAway does that, he said. By forceful suction, the diaphragm and phrenic nerve are activated, and at the same time, the water comes into the mouth and swallowing occurs. The vagus nerve is triggered and the hiccup goes away.

“We have tested it on a 1-year-old child. It worked,” Dr. Seifi said. “At any age that a person can drink water through a straw, it works for them.”

UT Health San Antonio, on behalf of The University of Texas System Board of Regents, patented this technology and granted an exclusive worldwide license to Aim Dynamics of Longmont, Colo., to market the invention.

“Honestly I am proud that this is a scientific device, because other ‘cures’ for hiccups are like voodoo things, but this is purely science,” Dr. Seifi said.

Dr. Seifi is an associate professor in the Department of Neurosurgery and a physician with UT Health Physicians, the clinical practice of the Joe R. and Teresa Lozano Long School of Medicine. He oversees the care of patients in University Hospital’s Neuro Intensive Care Unit.

Dr. Seifi received his medical degree in 1996 from Shiraz University of Medical Sciences (SUMS) in Iran. He did his first residency in anesthesiology and critical care at SUMS and his second residency in internal medicine at New Jersey’s AtlantiCare Regional Medical Center. His education culminated with two years of a neuro-critical care fellowship at Thomas Jefferson University in Philadelphia.

# # #

The Long School of Medicine at The University of Texas Health Science Center at San Antonio is named for Texas philanthropists Joe R. and Teresa Lozano Long. The school is the largest educator of physicians in South Texas, many of whom remain in San Antonio and the region to practice medicine. The school teaches more than 900 students and trains 800 residents each year. As a beacon of multicultural sensitivity, the school annually exceeds the national medical school average of Hispanic students enrolled. The school’s clinical practice is the largest multidisciplinary medical group in South Texas with 850 physicians in more than 100 specialties. The school has a highly productive research enterprise where world leaders in Alzheimer’s disease, diabetes, cancer, aging, heart disease, kidney disease and many other fields are translating molecular discoveries into new therapies. The Long School of Medicine is home to a National Cancer Institute-designated cancer center known for prolific clinical trials and drug development programs, as well as a world-renowned center for aging and related diseases.

The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio, is one of the country’s leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 37,000 alumni who are leading change, advancing their fields, and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit http://www.uthscsa.edu.

Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube, and visit our online Newsroom.

To see how we are battling COVID-19, read inspiring stories on Impact.